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Edited by Gianni CesareniAbstract To understand diﬀerential time activation of nuclear
factor jB (NF-jB) and the temporal features of the downstream
pro-inﬂammatory cytokines’ [tumour-necrosis-factor-a (TNF-a)
and IP-10] mRNA levels in myeloid diﬀerentiation primary-re-
sponse protein 88 (MyD88) knockouts (KOs), I developed a
computational model of the TLR4 pathway. The result suggests
that the late phase expression of NF-jB activity observed in
MyD88 KOs is possibly due to a number of novel intermediates
acting along the MyD88-independent pathway. I also simulate
that the TNF-a levels will increase at a longer time in MyD88
KOs, not previously mentioned.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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activity1. Introduction
The Toll-like receptor (TLR) signaling pathways form an
integral part of the innate immunity. These receptors, with
13 known members, function to recognize conserved patho-
gen-associated molecular patterns related to microorganisms
(such as lipopolysaccharide and double-stranded RNA) and
triggers not only microbial clearance, but also induces the pro-
duction of immunoregulatory chemokines and cytokines. This
is performed predominantly through the activation of the tran-
scription factors nuclear factor jB (NF-jB), interferon (IFN)
regulatory factor 3 (IRF-3) and AP-1 [1,2]. As these transcrip-
tion factors’ activity is also aberrated in many human pathol-
ogy (especially NF-jB), the understanding of the diﬀerential
time activation of this transcription factor is important as itAbbreviations: IKK, inhibitor of nuclear factor-jB-kinase; IRAK-1,
IL-1R associated kinase 1; IRF-3, interferon (IFN) regulatory factor 3;
JNK, c-Jun N-terminal kinase; LPS, lipopolysaccharide; MAP, mito-
gen-activated protein; MKK, map kinase kinase; MyD88, myeloid
diﬀerentiation primary-response protein 88; NF-jB, nuclear factor jB;
TAB1, TAK1-binding protein 1; TAK1, transforming-growth-factor-
b-activated kinase; TNF-a, tumour-necrosis-factor a; TRAF-6,
tumour-necrosis-factor-receptor-associated factor 6; TRAM, TRIF-
related adaptor molecule; TRIF, TIR-domain-containing adaptor
protein inducing IFN-b
*Fax: +65 6478 9047.
E-mail address: kumars@bii.a-star.edu.sg (K. Selvarajoo).
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.01.046could allow us to devise strategies to speciﬁcally modulate its
activity to develop therapeutic treatment.
The cytoplasmic region of TLR consists of Toll-interleukin
receptor (TIR) domain that mediates the association of adap-
tor molecules of which the best characterized is the myeloid
diﬀerentiation primary-response protein 88 (MyD88). The
recruitment of MyD88 results in the binding of IRAK-4 to
MyD88 at the receptor and induces the association of
IL-1R-associated kinase 1 (IRAK-1). IRAK-1 becomes phos-
phorylated and recruits tumour-necrosis-factor-receptor-asso-
ciated factor 6 (TRAF-6). Phosphorylated IRAK-1 and
TRAF-6 dissociates from the receptor and forms a complex
with transforming-growth-factor-b-activated kinase (TAK)1,
TAK-binding protein (TAB)1 and TAB2. This results in (i)
the activation of AP-1 through mitogen-activated protein
(MAP) kinases and, (ii) the activation of NF-jB through
IjB kinases (IKK a, b and c). The AP-1 and NF-jB translo-
cate into the nucleus and induce the expression of many proin-
ﬂammatory genes. More recently, the stimulation of TLRs on
MyD88 deﬁcient mice have revealed the induction of NF-jB
activity through the active signal received from TIR-domain-
containing adaptor protein inducing IFN-b (TRIF) and
IRF-3. This other cascade of signal has been termed the
‘MyD88-independent’ pathway [1,3].
The TLR signaling ﬁeld is evolving fairly rapidly over the last
few years [4–7]. Timecourse experiments have been performed
on these pathways to understand the regulatory roles of diﬀer-
ent adaptors and signaling molecules [8–12]. Despite this, the
detailed mechanism of the signal propagation through both
the MyD88-dependent and MyD88-independently pathway is
still poorly understood. Also, as we obtain more information
regarding these pathways, it becomes increasingly daunting to
analyse the data without the aid of appropriate analytical tools.
In this report, I discuss a computational model built to repre-
sent the TLR4 MyD88-dependent and MyD88-independent
pathways. My work is designed not primarily for the quantita-
tive simulation of the TLR4 pathway phenotype, but rather, for
the qualitative understanding of the features of the signaling
cascades. Speciﬁcally, I would like to address why there is a
time delay response of NF-jB activity to lipopolysaccharide
(LPS) stimulus under MyD88 knock-out conditions [3,10,13].2. Methods
2.1. Creation of reference model
The modeling strategy consists of the following steps (Fig. 1). Step 1:
A basic model is ﬁrst developed using the pathways obtained from
published source, the KEGG database [14]. In this step, mathematicalblished by Elsevier B.V. All rights reserved.
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dix 1A). Step 2: The parameters of the model (e.g., rate constants) are
selected such that the model predictions ﬁts the experimental data ob-
tained from published sources accurately. Step 3: If model simulations
accurately predict the phenotype of a particular cell type to a given
stimulus [e.g., wildtype (WT) tumour-necrosis-factor a (TNF-a)
expression with LPS stimulus], I accept the model and called it the ref-
erence model (Step 5). Otherwise, I move to step 4. Step 4: This is an
iterative procedure where I modify both the model expressions (e.g.,
adding an additional reaction or changing the reaction rule) and
parameters until I improve the accuracy of the model predictions be-
fore accepting the model.
2.2. Testing of reference model (e.g., intracellular perturbation)
Once the reference model has been created, the next step is to ‘per-
turb’ the model at any step within the pathway (Step 6) and compare
the model predictions with suitable experimental phenotype (Step 7).
For example, in the case of MyD88 knock-out (KO) experiments, I
‘knocked-out’ the equivalent step of the reference model, in silico
(i.e., removing the reaction at that step by setting the relevant rate con-
stant zero), and observing the overall phenotype. If the simulation re-
sults are similar to the experimental phenotype, then the model is
robust (Step 9). That is, the same model predicts the experimental phe-
notypes accurately under WT and KO conditions for a given stimulus.
Otherwise, the model is modiﬁed (Step 8 or even move to Step 4) until
favorable simulations are observed (Step 9) (Fig. 1).
In this paper, I performed the testing of our reference model to pre-
dict three phenotype (NF-jB, TNF-a and IP-10) under two experimen-
tal conditions (WT and knockout) simultaneously.3. Results and discussion
The TLR4 signaling pathway constitutes of what we know
today as the MyD88-dependent and MyD88-independent
pathways [1,2]. It has been demonstrated in MyD88-deﬁcient
mice, the existence of delayed kinetics of NF-jB activity.
Though this result has been reproduced on several occasions[3,10,13] and has been implicated as the role played by the
MyD88-independent pathway, till today, there is no mechanis-
tic reasoning for the delayed response. Furthermore, it is still a
daunting question whether proinﬂammatory cytokines such as
the TNF-a and IL-1, which requires the activation of the NF-
jB transcriptional factors, would also become expressed at a
later phase. Though there is no evidence to support this as
yet from the experimental perspective, I approached this ques-
tion in a systemic way.
In this report, I have developed a computational model that
predicts the concentrations of TLR4 signaling molecules with
respect to time. An initial reference model was created to pre-
dict the activity of NF-jB in WT cells. Fig. 3A shows the rel-
ative expression of NF-jB as a function of time for an active
TLR4 state. The model parameters were chosen to simulate
the expression of NF-jB as previously observed, Fig. A.3.1
and [3]. Next, I performed in silico KO of the equivalent step
in the model that represents the MyD88 KO. The model sim-
ulation resulted in the expression of NF-jB that looks similar
to the WT phenotype, that is, no noticeable delay in kinetics
(Fig. 3B). This result does not match as what has been previ-
ously observed [3,10,13].
As mentioned earlier, the reference model was initially devel-
oped using the pathway obtained from the KEGG database
(Fig. 2A). In my model, when I disrupt the activity of the
MyD88-dependent pathway (i.e., MyD88 KO), the NF-jB
expression is purely the result of the MyD88-independent
pathway (Fig. 2A). One way that I could obtain the desired re-
sult is to manipulate this pathway (Step 8, Fig. 1). I next chan-
ged the rate constants of all the reactions with lower values to
represent slower rate, the results did improve but the peak va-
lue decreased signiﬁcantly (Fig. 3C). Then, I changed the
kinetics of each reaction to diﬀerent types of expressions
(e.g., Michaelis–Menten) and result did not improve (data
not shown). However, when I chose to increase the number
of intermediates in the pathway, in combination with slower
rate constants, the model simulations started to improve. After
the incorporation of a few unknown intermediates, I was able
to obtain the desired delayed time proﬁle of NF-jB (Fig. 3D
and Fig. A.3.1). This result suggests that in the MyD88-inde-
pendent pathways, there may exist, ‘unaccounted’ intermedi-
ates that delays the signaling of NF-jB. (One other possible
explanation for the delay in kinetics is to consider large spatial
distance that the molecules in the independent pathways needs
to travel before reaction could take place. This is quite unlikely
as the spatial distance issue cannot be speciﬁcally long for
independent pathway molecules only.)
A computational model is deemed satisfactory only if it is
able to predict more than one experimental phenotype. I then
decided to focus on the expression of the chemokine IP-10 and
proinﬂammatory cytokine TNF-a. Using the latter model
(with the newly included intermediates, Fig. 2B), I reselected
the parameters such that it simulates the WT mRNA expres-
sion of IP-10 and TNF-a collectively (Fig. 4A and 5A) (new
reference model). Next, I performed the in silico MyD88 KO
on this reference model. Fig. 4B shows the simulation of the
relative mRNA expression of IP- 10 for MyD88 KO. We
can observe the model simulation qualitatively mimics the
experimental phenotype (Fig. A.3.2, [10]). We notice that
though the WT and MyD88 KO proﬁles looks similar, the rel-
ative expression of IP-10 mRNA is higher for the MyD88 KO
case. The computational reasoning is that as the ﬂux through
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Fig. 2A. Schematic of TLR4 MyD88-dependent and MyD88-independent signaling pathways. See text for details.
K. Selvarajoo / FEBS Letters 580 (2006) 1457–1464 1459the dependent pathway is blocked in MyD88 KO, and since
both MyD88-dependent and MyD88-independent signal are
necessary (mutually and not exclusively) for IP-10 induction,
shutting one pathway leads to higher peak expression.
Focusing next on TNF-a expression, we observe that the
simulation accurately tracks the WT phenotype throughout
the whole time course (Fig. A.3.3, [8]). One interesting point
to note is the kink observed for the WT phenotype [8]. Iinitially thought that this might be of some experimental arti-
fact, but later, from the simulation results, realize this could be
the consequence of the delayed expression of NF-jB caused by
the MyD88-independent pathway. In my model, the incorpo-
ration of intermediates with slower net ﬂux rate resulted in
such a proﬁle (Fig. 5A). As for the MyD88 KO, previously
it has been observed for, up to 1.5 h, no signiﬁcant levels of
TNF-a in mice serum (Fig. A.3.4, [3]). However, our simula-
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1460 K. Selvarajoo / FEBS Letters 580 (2006) 1457–1464tion suggests delayed expression of TNF-a (Fig. 5B). This
could possibly imply that the serum levels of TNF-a could rise
in the MyD88 deﬁcient mice to LPS stimulus if measured at
longer time periods, say after 12 h.
I believe that the model predicting late phase expression of
TNF-a could possibly be true as it requires the NF-jB tran-scription factor. Since, NF-jB activity is delayed during
MyD88 KO condition [3,10,13], all processes that requires this
transcriptional factor could also be slowed, though further
experiments at longer time duration is required to prove this
suggestion derived from a computational modeling
approach.
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Fig. 3. (A) The simulated time course relative expression of NF-jB in the nucleus for the WT model. The x-axis represents the time in arbitrary units
(au) and the y-axis represents the arbitrary expression levels of NF-jB. The peak expression of NF-jB is observed at around 12 au of time. I have
assumed that the translocation of NF-jB into the nucleus will increase the binding activity of NF-jB onto the DNA. Hence, the activity of NF-jB is
proportionate to the NF-jB expression in the nucleus. (B) The simulated time course relative expression of NF-jB in the nucleus for the MyD88 KO
model. The MyD88 KO model is the same model as the WT model but with the rate constant for the reaction a (Fig. 2A) set to zero. The peak
expression of NF-jB is observed at around 10 au time. (C) The simulated time course relative expression of NF-jB in the nucleus for the MyD88 KO
model with slower rate constant upstream of IKKe/TBK1 (step (b) of Fig. 2A). Peak NF-jB expression is observed at 23 au time. (D) The simulated
time course relative expression of NF-jB in the nucleus for the MyD88 KO model with the addition of 5 intermediates after TRIF/TRAM molecules
(Fig. 2B). Peak NF-jB expression is observed at 30 au time, a clear indication of delayed kinetics.
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Computational models can be useful to integrate informa-
tion, gained from multitudes of experiments, to generate novel
hypotheses that may be of great interest and value. I have de-
vised a computational model for Toll-like receptor 4 signaling
pathways that gives insights to some possible mechanistic
properties of the pathways. The result suggests that the
MyD88-independent pathway may consist of few unidentiﬁed
intermediates (protein or protein complexes) upstream of
IKKe/TBK1. This hypothesis has been substantiated by recent
ﬁnding that TRAF3 is recruited to the adaptor TRIF and is
required for marshalling the protein kinase TBK1 into TIR
signalling complexes, thereby explaining its unique role in acti-
vation of the IFN response [15]. McGettrick and O’Neill have
also shown that phosphorylation of TRIF-related adaptor
molecule (TRAM) by PKCe is essential for IRF3 activation
[16]. Another interesting prediction of the model is that
TNF-a, which until today is believed to be absent during
MyD88 KO, may indeed be present at a later phase.Acknowledgements: Santosh Mishra and Subhra Biswas of Bioinfor-
matics Institute have contributed important discussions that led to
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A.1. The model
My model begins with the TLR4 receptor in an active state
through the binding of LPS (Fig. 2). The active signal triggers
both the MyD88 dependent and independent pathways. For
the MyD88 dependent pathway, the signaling reactions are
(i) the association of MyD88 to the TLR4 receptor, (ii) the
association of IRAK1 and IRAK4 to the MyD88 at the recep-
tor, (iii) IRAK-MyD88 complex activates TRAF6, (iv)
TRAF6 stimulates the formation of TAB–TAK complex, (v)
TAB–TAK complex triggers map kinase kinase (MKK)4,
MKK3/6and IjB kinases (IKK a, b and c), (vi) MKK4 acti-
vates c-Jun N-terminal kinase (JNK) (vii) MKK3/6 activates
p38, (viii) IjB kinases activatesNF-jB, (ix) p38 and JNK stim-
ulates AP-1, (x) NF-jB translocates to the nucleus, (xi) AP-1
translocates into the nucleus, (xii) NF-jB and AP-1 binds to
respective binding sites to induce TNF-a mRNA expression,
(xiii) degradation of TNF-a mRNA.
The following constitutes the MyD88 independent pathway:
(a) the association of TRIF/TRAM to the TLR4 receptor, (b)
the association of IKKe with TRIF/TRAM, (c) the activation
of IRF-3 and the induction of NF-jB, (d) translocation of
IRF-3 to the nucleus, (e) the translocation of NF-jB to the nu-
cleus, (f) the binding of NF-jB and IRF-3 for the expression of
IP-10 mRNA, (g) degradation of IP-10 mRNA.
The kinetics of each signaling reaction within the cytoplasm
is based upon the principle of mass action because in signaling
pathways the condition that substrate concentration is much
larger than the enzyme is usually not true (Table A.2.1 shows
the equations and parameters used to model each reaction).
Moreover, only ﬁrst-order equations are used as detailed ki-
netic data of the TLR4 signaling pathways are unavailable
[17]. Within the nucleus, as the conditions are such that the
transcription rate depends on the concentration of the active
transcription factors with limiting number of RNA polymerase
complexes, the transcription rate will have a saturated value. I
describe the TNF-a and IP-10 transcription rates with kinetics
of the hyperbolic type equation [18] (Table A.2.1).
Once I have assembled the TLR4 signaling pathways (Step
1) with the appropriate reactions and reaction rules, I selected
the values of the relevant parameters for each step such a way
that they reproduce the time series proﬁle of WT NF-jB
activity, TNF-a and IP-10 mRNA expression levels for LPS
stimulus (Step 2) [3,8,10]. I, ﬁrst, was able to ﬁt the model
with experimental ﬁndings successfully to the WT phenotype
(Step 3). I referred this model as the reference model (Step 5)
and subsequently performed ‘in silico’ KO experiments to rep-
resent MyD88 KO (Step 6). Initially, I did not obtain a good
ﬁt but subsequently, with modiﬁcation to the reaction steps
and rules (Step 8, then Step 4) the overall model ﬁt improved.
After some rounds of modiﬁcations to the initial reference
model, I obtained an overall good ﬁt and a robust model
(Step 9).
Table A.2.1
No. Reaction Kinetic formula Parameter values
MyD88 dependent pathway
1 TLR4MMyD88 kf1 · TLR4  kb1 ·MyD88 kf1 = 0.1, kb1 = 0.0001
kf1 = 0, kb1 = 0 (MyD88 KO)
2 MyD88M IRAK4/1 kf2 ·MyD88  kb2 · IRAK4/1 kf2 = 1.0, kb2 = 0.001
3 IRAK4/1M TRAF6 kf3 · IRAK4/1  kb3 · TRAF6 kf3 = 1.0, kb3 = 0.001
4 TRAF6M TABTAK kf4 · TRAF6  kb4 · TABTAK kf4 = 1.0, kb4 = 0.001
5 TABTAKMMKK4 kf5 · TABTAK  kb5 ·MKK4 kf5 = 0. 1, kb5 = 0.0001
6 TABTAKMMKK3/6 kf6 · TABTAK  kb6 ·MKK3/6 kf6 = 0.1, kb6 = 0.0001
7 TABTAKM IKKabc kf7 · TABTAK  kb7 · IKKabc kf7 = 1.0, kb7 = 0.001
8 MKK4M JNK kf8 ·MKK4  kb8 · JNK kf8 = 1.0, kb8 = 0.0001
9 JNKM AP-1_c kf9 · JNK  kb9 · AP-1_c kf9 = 1.0, kb9 = 0.0001
10 MKK3/6M p38 kf10 ·MKK3/6  kb10 · p38 kf10 = 1. 0, kb10 = 0.0001
11 p38M AP-1_c kf11 · p38  kb11 · AP-1_c kf11 = 1.0, kb11 = 0.0001
12 AP-1_cﬁ AP-1_n kf12 · AP-1_c kf12 = 0.1
13 IKKabcM IkBa/NF-jB kf13 · IKKabc  kb12 · IkBa/NF-jB kf13 = 1.0, kb12 = 0.001
14 IkBa/NF-jBM NF-jB_c kf14 · IkBa/NF-jB  kb13 · NF-jB_c kf14 = 1.0, kb13 = 0.001
15 NF-jB_cﬁ NF-jB_n kf15 · NF-jB_c kf15 = 0.01
MyD88 independent pathway
16 TLR4M TRIF/TRAM* kf16 · TLR4  kb14 · TRIF/TRAM kf16 = 0.13, kb14 = 0.0001
17 TRIF/TRAMM IND1 kf17 · TRIF/TRAM  kb15 · IND1 kf17 = 0.02, kb15 = 0.0001
18 IND1M IND2 kf18 · IND1  kb16 · IND2 kf18 = 0.02, kb16 = 0.0001
19 IND2M IND3 kf19 · IND2  kb17 · IND3 kf19 = 0.02, kb17 = 0.0001
20 IND3M IND4 kf20 · IND3  kb18 · IND4 kf20 = 0.02, kb18 = 0.0001
21 IND4M IND5 kf21 · IND4  kb19 · IND5 kf21 = 0.02, kb19 = 0.0001
22 IND5M IKKe/TBK1 kf22 · IND5  kb20 · IKKe/TBK1 kf22 = 0.02, kb20 = 0.0001
23 IKKe/TBK1M IRF3_c kf23 · IND5  kb21 · IRF3_c kf23 = 0.01, kb21 = 0.0001
24 IKKe/TBK1M IkBa/NF-jB kf24 · IKKe/TBK1  kb22 · IkBa/NF-jB kf24 = 0.02, kb22 = 0.0001
25 IRF-3_cﬁ IRF-3_n kf25 · IRF3_c kf25 = 1.0
In the nucleus
26 IRF-3_nﬁ IP-10 V max1IRF-3 nKm1þIRF-3 n Km1 = 0.4, Vmax1 = 0.6
27 NF-jB_nﬁ IP-10 V max2NF-jB nKm2þNF-jB n Km2 = 0.4, Vmax2 = 0.7
28 NF-jB_nﬁ TNF-a V max3NF-jB nKm3þNF-jB n Km3 = 0.3, Vmax3 = 0.9
29 AP-1_nﬁ TNF-a V max4AP-1 nKm4þAP-1 n Km4 = 0.3, Vmax4 = 0.5
30 IP-10ﬁ IP-10_deg kf26 · IP-10 kf26 = 0.011
31 TNF-aﬁ TNF-a_deg kf27 · TNF-a kf27 = 0.003
K. Selvarajoo / FEBS Letters 580 (2006) 1457–1464 1463A.2. The model details
See Table A.2.1.
The position of TRIF/TRAM could be interchangeable with
any of the intermediates (IND) as we do not have data in the
cytoplasm to compare and know the exact location in the path-
way for TRIF/TRAM.Fig. A.3.1. Figure obtained from [3]. Delayed activation of the MAP kina
Peritoneal macrophages from WT and MyD88 KO mice were stimulated wi
were then prepared, and NF-jB activity was determined by electrophoretic mo
experiments.The units for the parameters of ﬁrst order equations are 1/s
and for the Michaelis–Menten type equations, Vmax’s units are
1/s and Km’s hold arbitrary units.
A.3. Literature comparison
See Figs. A.3.1–A.3.4.se family after lipid A stimulation in MyD88 KO macrophages. (B)
th 2.0 lg/ml compound 506 for the indicated periods. Nuclear extracts
bility shift assay. Similar results were obtained from three independent
Fig.A.3.2. Figure obtained from [10]. Induction of IFN-inducible genes
in response to lipid A in MyD88-deﬁcient macrophages. (A) Thiogly-
collate-elicited peritoneal macrophages from wild-type, MyD88-
deﬁcient, and TLR4-deﬁcient mice were stimulated with 1.0 lg/ml of
synthetic lipid A (compound 506) for 4 or 8 h. Total RNA (5.0 lg) was
electrophoresed, transferred, and hybridized with 32P-labeled probes
speciﬁc for IP-10, GARG16, IRG-1, COX-2, or GAPDH.
Fig. A.3.3. Figure obtained from [8]. Total RNA was isolated from
bone-marrow-derived macrophages at the indicated time points for
real-time PCR analysis. The x-axis is time (h) and the y-axis is relative
mRNA levels. Filled squares represent WT macrophages and open
squares represent AA macrophages.
Fig. A.3.4. Figure obtained from [3]. Age-matched wild-type (n = 8)
and MyD88 KO (n = 8) mice were injected with 1.0 mg of O55:B5 LPS.
Serum concentrations of TNF-a taken at 0 and 1.5 h after LPS
injection, measured by speciﬁc enzyme-linked immunosorbent assay.
ND, not detected.
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